Multifactorial pathways in burn injury-induced chronic pain: novel targets and their pharmacological modulation

Raja SN, Carr DB, Cohen M et al (2020) The revised IASP definition of pain: Concepts, challenges, and compromises. Pain 161:1976 Wang Y, Beekman J, Hew J et al (2018) Burn injury: Challenges and advances in burn wound healing, infection, pain and scarring. Adv Drug Deliv Rev 123:3–17. https://doi.org/10.1016/j.addr.2017.09.018 Newberry JA, Bills CB, Pirrotta EA et al (2019) Timely access to care for patients with critical burns in India: a prehospital prospective observational study. Emerg Med J 36:176–182 Nelson S, Conroy C, Logan D (2019) The biopsychosocial model of pain in the context of pediatric burn injuries. Eur J pain 23:421–434 Klifto KM, Dellon AL, Hultman CS (2021) Prevalence and associated predictors for patients developing chronic neuropathic pain following burns. Burn Trauma 8. https://doi.org/10.1093/BURNST/TKAA011 Fernandes V, Sharma D, Vaidya S et al (2018) Cellular and molecular mechanisms driving neuropathic pain: recent advancements and challenges. Expert Opin Ther Targets 22:131–142. https://doi.org/10.1080/14728222.2018.1420781 Wood JN (2020) The oxford handbook of the neurobiology of pain. Oxford University Press Akhilesh UA, Gadepalli A et al (2022) Unlocking the potential of TRPV1 based siRNA therapeutics for the treatment of chemotherapy-induced neuropathic pain. Life Sci 288:120187. https://doi.org/10.1016/j.lfs.2021.120187 Green DP, Ruparel S, Gao X et al (2016) Central activation of TRPV1 and TRPA1 by novel endogenous agonists contributes to mechanical and thermal allodynia after burn injury. 12:1–9. https://doi.org/10.1177/1744806916661725 Vandewauw I, Clercq K, De, Mulier M et al (2018) Letter A TRP channel trio mediates acute noxious. Nat Publ Gr. https://doi.org/10.1038/nature26137 Al-Shamlan F, El-Hashim AZ (2019) Bradykinin sensitizes the cough reflex via a B2 receptor dependent activation of TRPV1 and TRPA1 channels through metabolites of cyclooxygenase and 12-lipoxygenase. Respir Res 20. https://doi.org/10.1186/s12931-019-1060-8 Kádková A, Synytsya V, Krusek J et al (2017) Molecular basis of TRPA1 regulation in nociceptive neurons. A review.Physiol Res66 Choi S-I, Hwang SW (2018) Depolarizing Effectors of Bradykinin Signaling in Nociceptor Excitation in Pain Perception. Biomol Ther (Seoul) 26:255 Patil MJ, Salas M, Bialuhin S et al (2020) Sensitization of small-diameter sensory neurons is controlled by TRPV1 and TRPA1 association. FASEB J 34:287–302 Cai W, Cao J, Ren X et al (2015) shRNA mediated knockdown of Nav1. 7 in rat dorsal root ganglion attenuates pain following burn injury. BMC Anesthesiol 16:59 Shields SD, Cheng X, Üçeyler N et al (2012) Sodium channel Nav1. 7 is essential for lowering heat pain threshold after burn injury. J Neurosci 32:10819–10832 Meglič A, Perkovič-Benedik M, Podkrajšek KT, Bertok S (2014) Painful micturition in a small child: an unusual clinical picture of paroxysmal extreme pain disorder. Pediatr Nephrol 29:1643–1646 de Greef BTA, Hoeijmakers JGJ, Geerts M et al (2019) Lacosamide in patients with Nav1. 7 mutations-related small fibre neuropathy: a randomized controlled trial. Brain 142:263–275 Cregg JM, DePaul MA, Filous AR et al (2014) Functional regeneration beyond the glial scar. Exp Neurol 253:197–207 Cox JJ, Reimann F, Nicholas AK et al (2006) An SCN9A channelopathy causes congenital inability to experience pain. Nature 444:894–898. https://doi.org/10.1038/nature05413 Hagen NA, du Souich P, Lapointe B et al (2008) Tetrodotoxin for moderate to severe cancer pain: a randomized, double blind, parallel design multicenter study. J Pain Symptom Manage 35:420–429 Salas MM, Mcintyre MK, Petz LN et al (2015) Neuroscience Letters Tetrodotoxin suppresses thermal hyperalgesia and mechanical allodynia in a rat full thickness thermal injury pain model. Neurosci Lett 607:108–113. https://doi.org/10.1016/j.neulet.2015.09.031 Mao X-F, Ahsan MZ, Apryani E et al (2020) Dual µ-opioid receptor and norepinephrine reuptake mechanisms contribute to dezocine-and tapentadol-induced mechanical antiallodynia in cancer pain. Eur J Pharmacol 876:173062 Šutulović N, Grubač Ž, Šuvakov S et al (2019) Chronic prostatitis/chronic pelvic pain syndrome increases susceptibility to seizures in rats and alters brain levels of IL-1β and IL-6. Epilepsy Res 153:19–27 Alvarez P, Bogen O, Levine JD (2019) Interleukin 6 decreases nociceptor expression of the potassium channel KV1. 4 in a rat model of hand-arm vibration syndrome. Pain 160:1876 Vit J-P, Clauw DJ, Moallem T et al (2006) Analgesia and hyperalgesia from CRF receptor modulation in the central nervous system of Fischer and Lewis rats. Pain 121:241–260 Sosanya NM, Trevino AV, Chavez RL et al (2017) Sound-stress-induced altered nociceptive behaviors are associated with increased spinal CRFR2 gene expression in a rat model of burn injury. J Pain Res 10:2135 Huang P-C, Tsai K-L, Chen Y-W et al (2017) Exercise combined with ultrasound attenuates neuropathic pain in rats associated with downregulation of IL-6 and TNF-α, but with upregulation of IL-10. Anesth Analg 124:2038–2044 Stanojcic M, Chen P, Harrison RA et al (2014) Leukocyte infiltration and activation of the NLRP3 inflammasome in white adipose tissue following thermal injury. Crit Care Med 42:1357 Skoff AM, Zhao C, Adler JE (2009) Interleukin-1α regulates substance P expression and release in adult sensory neurons. Exp Neurol 217:395–400 Bernardino L, Xapelli S, Silva AP et al (2005) Modulator effects of interleukin-1β and tumor necrosis factor-α on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures. J Neurosci 25:6734–6744 Du G-H, Wang J-K, Richards JR, Wang J-J (2019) Genetic polymorphisms in tumor necrosis factor alpha and interleukin-10 are associated with an increased risk of cervical cancer. Int Immunopharmacol 66:154–161 Wolf SE (2016) TnF- α / il-10 ratio correlates with Burn severity and May serve as a risk Predictor of increased susceptibility to infections. 4:1–11. https://doi.org/10.3389/fpubh.2016.00216 Schaible H-G (2014) Nociceptive neurons detect cytokines in arthritis. Arthritis Res Ther 16:1–9 Zhang A, Lee YC (2018) Mechanisms for joint pain in rheumatoid arthritis (RA): from cytokines to central sensitization. Curr Osteoporos Rep 16:603–610 Schroder K, Tschopp J (2010) Review The Inflammasomes. 821–832. https://doi.org/10.1016/j.cell.2010.01.040 Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519–550 Ren K, Torres R (2009) Role of interleukin-1β during pain and inflammation. Brain Res Rev 60:57–64 Milligan ED, Watkins LR (2009) Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 10:23–36. https://doi.org/10.1038/nrn2533 Li T, Chen X, Zhang C et al (2019) An update on reactive astrocytes in chronic pain. J Neuroinflammation 16:1–13. https://doi.org/10.1186/s12974-019-1524-2 Biber K, Neumann H, Inoue K, Boddeke HWGM (2007) Neuronal ‘On’and ‘Off’signals control microglia. Trends Neurosci 30:596–602 Guan Z, Kuhn JA, Wang X et al (2016) Injured sensory neuron–derived CSF1 induces microglial proliferation and DAP12-dependent pain. Nat Neurosci 19:94–101 Sorkin LS, Svensson CI, Jones-Cordero TL et al (2009) Spinal p38 mitogen-activated protein kinase mediates allodynia induced by first-degree burn in the rat. J Neurosci Res 87:948–955. https://doi.org/10.1002/jnr.21905 Chang Y-W, Waxman SG (2010) Minocycline attenuates mechanical allodynia and central sensitization following peripheral second-degree burn injury. J Pain 11:1146–1154 Guasti L, Richardson D, Jhaveri M et al (2009) Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain. Mol Pain 5:35 Ma L, Zhou Y, Khan MAS et al (2019) Burn-induced microglia activation is associated with motor neuron degeneration and muscle wasting in mice. Shock 51:569 Fernandez-Lizarbe S, Montesinos J, Guerri C (2013) Ethanol induces TLR 4/TLR 2 association, triggering an inflammatory response in microglial cells. J Neurochem 126:261–273 Nicotra L, Loram LC, Watkins LR, Hutchinson MR (2012) Toll-like receptors in chronic pain. Exp Neurol 234:316–329. https://doi.org/10.1016/j.expneurol.2011.09.038 Zhang T, Zhang R, Xu B et al (2021) Spinal endomorphins attenuate burn-injury pain in male mice by inhibiting p38 MAPK signaling pathway through the mu-opioid receptor. Eur J Pharmacol 903:174139 Qiu J-L, Zhu W-L, Lu Y-J et al (2015) The selective mGluR5 agonist CHPG attenuates SO2-induced oxidative stress and inflammation through TSG-6/NF-κB pathway in BV2 microglial cells. Neurochem Int 85:46–52 Mai L, Zhu X, Huang F et al (2020) P38 Mitogen-Activated Protein Kinase and Pain. Life Sci 256:117885. https://doi.org/10.1016/j.lfs.2020.117885 Ipaktchi K, Mattar A, Niederbichler AD et al (2006) Attenuating burn wound inflammatory signaling reduces systemic inflammation and acute lung injury. J Immunol 177:8065–8071 Carter D, Warsen A, Mandell K et al (2014) Delayed topical p38 MAPK inhibition attenuates full-thickness burn wound inflammatory signaling. J Burn Care Res 35:e83–e92 Hoesel LM, Mattar AF, Arbabi S et al (2009) Local wound p38 MAPK inhibition attenuates burn-induced cardiac dysfunction. Surgery 146:775–786 Wang S, Lee J-S, Hyun J et al (2015) Tumor necrosis factor-inducible gene 6 promotes liver regeneration in mice with acute liver injury. Stem Cell Res Ther 6:20 Liu L, Song H, Duan H et al (2016) TSG-6 secreted by human umbilical cord-MSCs attenuates severe burn- induced excessive inflammation via inhibiting activations of P38 and JNK signaling. 1–13. https://doi.org/10.1038/srep30121 Padhy B, Kapuganti RS, Hayat B et al (2019) De novo variants in an extracellular matrix protein coding gene, fibulin-5 (FBLN5) are associated with pseudoexfoliation. Eur J Hum Genet 27:1858–1866 Yanagisawa H, Schluterman MK, Brekken RA (2009) Fibulin-5, an integrin-binding matricellular protein: Its function in development and disease. J Cell Commun Signal 3:337–347. https://doi.org/10.1007/s12079-009-0065-3 Zheng Q, Choi J, Rouleau L et al (2006) Normal wound healing in mice deficient for fibulin-5, an elastin binding protein essential for dermal elastic fiber assembly. J Invest Dermatol 126:2707–2714. https://doi.org/10.1038/sj.jid.5700501 Lee MJ, Roy NK, Mogford JE et al (2004) Fibulin-5 promotes wound healing in vivo. J Am Coll Surg 199:403–410 Hou X, Li H, Zhang C et al (2017) Overexpression of Fibulin-5 attenuates burn-induced inflammation via TRPV1/CGRP pathway. Exp Cell Res 357:320–327. https://doi.org/10.1016/j.yexcr.2017.05.029 Wozniak KM, Rojas C, Wu Y, Slusher BS (2012) The Role of Glutamate Signaling in Pain Processes and its Regulation by GCP II Inhibition. 1323–1334 Tiwari V, Tiwari V, He S et al (2016) Mas-related G protein-coupled receptors offer potential new targets for pain therapy. Transl Res pain itch 87–103 Chouhan D, Uniyal A, Gadepalli A et al (2020) Probing the Manipulated Neurochemical Drive in Alcohol Addiction and Novel Therapeutic Advancements. ACS Chem Neurosci 11:1210–1217. https://doi.org/10.1021/acschemneuro.0c00073 Uniyal A, Thakur V, Rani M et al (2021) Kinesin Nanomotors Mediated Trafficking of NMDA-Loaded Cargo as A Novel Target in Chronic Pain. ACS Chem Neurosci 12:2956–2963. https://doi.org/10.1021/acschemneuro.1c00319 Morgan M, Deuis JR, Frøsig-Jørgensen M et al (2018) Burn pain: a systematic and critical review of epidemiology, pathophysiology, and treatment. Pain Med 19:708–734 Stoicea N, Russell D, Weidner G et al (2015) Opioid-induced hyperalgesia in chronic pain patients and the mitigating effects of gabapentin. Front Pharmacol 6:104 Van Elstraete AC, Tirault M, Lebrun T et al (2008) The median effective dose of preemptive gabapentin on postoperative morphine consumption after posterior lumbar spinal fusion. Anesth Analg 106:305–308 Cuignet O, Pirson J, Soudon O, Zizi M (2007) Effects of gabapentin on morphine consumption and pain in severely burned patients. Burns 33:81–86. https://doi.org/10.1016/j.burns.2006.04.020 Li Z, Zhang B, Li W, Wang Q (2015) Clinical effects of gabapentin on the treatment of pruritus of scar resulting from deep partial-thickness burn. Chin J Burn 31:177–180. https://doi.org/10.3760/cma.j.issn.1009-2587.2015.03.005 Jun JH, Yaksh TL (1998) The effect of intrathecal gabapentin and 3-isobutyl γ-aminobutyric acid on the hyperalgesia observed after thermal injury in the rat. Anesth Analg 86:348–354. https://doi.org/10.1097/00000539-199802000-00025 Gray P, Williams B, Cramond T (2008) Successful use of gabapentin in acute pain management following burn injury: A case series. Pain Med 9:371–376. https://doi.org/10.1111/j.1526-4637.2006.00149.x Chinchilla PA, Moyano J (2021) Efficacy of opioids and non-opioid analgesics in the treatment of post procedure pain of burned patients: a narrative review. Brazilian J Anesthesiol (English Ed. https://doi.org/10.1016/j.bjane.2021.07.022 Jones TL, Sorkin LS (2005) Activated PKA and PKC, but not CaMKIIα, are required for AMPA/kainate-mediated pain behavior in the thermal stimulus model. Pain 117:259–270 Wang H, Woolf CJ (2005) Pain TRPs. Neuron 46:9–12 Jones TL, Sorkin LS (2004) isoxazolepropionic Acid / Kainate Receptors Mediate Development, but Not Maintenance, of Secondary Allodynia Evoked by First-Degree Burn in the Rat. Pharmacology 310:223–229. https://doi.org/10.1124/jpet.103.064741.sensitization District SQ, Hassanpour-Ezatti M, Haghparast A (2012) Glutamate receptors in nucleus accumbens can modulate canabinoid-induced antinociception in rats basolateral amygdala.Basic Clin Neurosci3 Bleakman D, Alt A, Nisenbaum ES (2006) Glutamate receptors and pain. Seminars in cell & developmental biology. Elsevier, pp 592–604 Warncke T, Stubhaug A, Jørum E (1997) Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo. Pain 72:99–106. https://doi.org/10.1016/s0304-3959(97)00006-7 Zieglgänsberger W (2019) Substance P and pain chronicity. Cell Tissue Res 375:227–241 Lembeck F, Gamse R (1982) Substance P in peripheral sensory processes. Subst P Nerv Syst 91:35–54 Mantyh PW, Rogers SD, Honore P et al (1997) Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor. Sci (80-) 278:275–279 Seybold VS (2009) The role of peptides in central sensitization.Sens Nerves451–491 Bardoni R, Torsney C, Tong C-K et al (2004) Presynaptic NMDA receptors modulate glutamate release from primary sensory neurons in rat spinal cord dorsal horn. J Neurosci 24:2774–2781 Marchand F, Perretti M, McMahon SB (2005) Role of the immune system in chronic pain. Nat Rev Neurosci 6:521–532 Shinohara K, Watabe AM, Nagase M et al (2017) Essential role of endogenous calcitonin gene-related peptide in pain‐associated plasticity in the central amygdala. Eur J Neurosci 46:2149–2160 Natura G, von Banchet GS, Schaible H-G (2005) Calcitonin gene-related peptide enhances TTX-resistant sodium currents in cultured dorsal root ganglion neurons from adult rats. Pain 116:194–204 Onuoha GN, Alpar EK (2001) Levels of vasodilators (SP, CGRP) and vasoconstrictor (NPY) peptides in early human burns. 253–257 Wang D, Tawfik VL, Corder G et al (2018) Functional divergence of delta and mu opioid receptor organization in CNS pain circuits. Neuron 98:90–108 Scherrer G, Imamachi N, Cao Y-Q et al (2009) Dissociation of the opioid receptor mechanisms that control mechanical and heat pain. Cell 137:1148–1159 Sánchez-Brualla I, Boulenguez P, Brocard C et al (2018) Activation of 5-HT 2A Receptors Restores KCC2 Function and Reduces Neuropathic Pain after Spinal Cord Injury. Neuroscience 387:48–57. https://doi.org/10.1016/j.neuroscience.2017.08.033 Guan Y, Johanek LM, Hartke TV et al (2008) Peripherally acting mu-opioid receptor agonist attenuates neuropathic pain in rats after L5 spinal nerve injury. Pain 138:318–329 Emery MA, Bates MLS, Wellman PJ, Eitan S (2017) Burn injury decreases the antinociceptive effects of opioids. Behav Pharmacol 28:285–293 Uniyal A, Gadepalli A, Akhilesh, Tiwari V (2020) Underpinning the Neurobiological Intricacies Associated with Opioid Tolerance. ACS Chem Neurosci 11:830–839. https://doi.org/10.1021/acschemneuro.0c00019 Tiwari V, He SQ, Huang Q et al (2020) Activation of µ-d Opioid receptor heteromers inhibits neuropathic pain behavior in rodents. Pain 161:842–855. https://doi.org/10.1097/j.pain.0000000000001768 Tiwari V, Anderson M, Yang F et al (2018) Peripherally Acting µ-Opioid Receptor Agonists Attenuate Ongoing Pain-associated Behavior and Spontaneous Neuronal Activity after Nerve Injury in Rats. Anesthesiology 128:1220–1236. https://doi.org/10.1097/ALN.0000000000002191 Vaidya S, Shantanu PA, Tiwari V (2021) Attenuation of ongoing neuropathic pain by peripheral acting opioid involves activation of central dopaminergic neurocircuitry. Neurosci Lett 754:135751. https://doi.org/10.1016/j.neulet.2021.135751 Tiwari V, Yang F, He S-Q et al (2016) Activation of peripheral µ-opioid receptors by dermorphin [D-Arg2, Lys4](1–4) amide leads to modality-preferred inhibition of neuropathic pain. Anesthesiology 124:706–720 Danilov A, Kurganova J (2016) Melatonin in chronic pain syndromes. Pain Ther 5:1–17 Maldonado M-D, Murillo-Cabezas F, Calvo J-R et al (2007) Melatonin as pharmacologic support in burn patients: A proposed solution to thermal injury–related lymphocytopenia and oxidative damage. Crit Care Med 35:1177–1185 Ng KY, Leong MK, Liang H, Paxinos G (2017) Melatonin receptors: distribution in mammalian brain and their respective putative functions. Brain Struct Funct 222:2921–2939 de Zanette SA, Vercelino R, Laste G et al (2014) Melatonin analgesia is associated with improvement of the descending endogenous pain-modulating system in fibromyalgia: a phase II, randomized, double-dummy, controlled trial. BMC Pharmacol Toxicol 15:40 Ulmann L, Hatcher JP, Hughes JP et al (2008) Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J Neurosci 28:11263–11268 Meng X, Gao J, Zuo J-L et al (2017) Toll-like receptor-4/p38 MAPK signaling in the dorsal horn contributes to P2X4 receptor activation and BDNF over-secretion in cancer induced bone pain. Neurosci Res 125:37–45 Lee-Hotta S, Uchiyama Y, Kametaka S (2019) Role of the BDNF-TrkB pathway in KCC2 regulation and rehabilitation following neuronal injury: a mini review. Neurochem Int 128:32–38 Yang H, Feng G-D, Liang Z et al (2012) In vitro beneficial activation of microglial cells by mechanically-injured astrocytes enhances the synthesis and secretion of BDNF through p38MAPK. Neurochem Int 61:175–186 Solway B, Bose SC, Corder G et al (2011) Tonic inhibition of chronic pain by neuropeptide Y. Proc Natl Acad Sci 108:7224–7229 Yin K, Deuis JR, Lewis RJ, Vetter I (2016) Transcriptomic and behavioural characterisation of a mouse model of burn pain identify the cholecystokinin 2 receptor as an analgesic target. Mol Pain 12:1–13. https://doi.org/10.1177/1744806916665366 Zeng Q, Man R, Luo Y et al (2017) IRF-8 is involved in Amyloid-β1–40 (Aβ1–40)-induced microglial activation: a new implication in Alzheimer’s disease. J Mol Neurosci 63:159–164 Rao PN, Mainkar O, Bansal N et al (2021) Flavonoids in the Treatment of Neuropathic Pain. Curr Pain Headache Rep 25. https://doi.org/10.1007/s11916-021-00959-y Shao B, Wei W, Ke P et al (2014) Activating cannabinoid receptor 2 alleviates pathogenesis of experimental autoimmune encephalomyelitis via activation of autophagy and inhibiting NLRP 3 inflammasome. CNS Neurosci Ther 20:1021–1028 Ge M-M, Zhou Y-Q, Tian X-B et al (2020) Src-family protein tyrosine kinases: A promising target for treating chronic pain. Biomed Pharmacother 125:110017 Nie L, Ye W-R, Chen S et al (2021) Src family kinases in the central nervous system: their emerging role in pathophysiology of migraine and neuropathic pain. Curr Neuropharmacol 19:665–678 Clark AK, Yip PK, Grist J et al (2007) Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. Proc Natl Acad Sci 104:10655–10660 Ye L, Xiao L, Yang SY et al (2017) Cathepsin S in the spinal microglia contributes to remifentanil-induced hyperalgesia in rats. Neuroscience 344:265–275